Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2012
09/04/2012US8257741 Solid pharmaceutical dispersions with enhanced bioavailability
09/04/2012US8257740 Pharmaceutical composition of nanoparticles
09/04/2012US8257739 low-solubility drug (especially CCR-1 inhibitors) and a concentration-enhancing polymer; drug-rich regions are interspersed throughout drug-poor, polymer-rich regions; storage stability
09/04/2012US8257738 Encapsulation compositions and process for preparing the same
09/04/2012US8257737 Providing a platelet-containing fluid sample at a first temperature; adding to the sample, an amount of an exothermic salt sufficient to activate the platelets
09/04/2012US8257735 Method of increasing the bioavailability of recombinant human insulin isophane in a patient
09/04/2012US8257734 PQS and its conjugates as adjuvants and their uses in pharmaceutical compositions
09/04/2012US8257733 Methods and compositions for treating proliferative diseases
09/04/2012US8257732 Clay-based hemostatic agents and devices for the delivery thereof
09/04/2012US8257731 Devices and methods for the delivery of molecular sieve materials for the formation of blood clots
09/04/2012US8257730 Steroid-containing sustained release intraocular implants and related methods
09/04/2012US8257718 Apparatus and method for manufacture of cosmetic applicator
09/04/2012US8257686 Compositions and methods relating to prevention of chemotherapy-induced alopecia
09/04/2012US8257685 Swellable particles for drug delivery
09/04/2012US8257325 Venous access port with molded and/or radiopaque indicia
09/04/2012CA2610646C Prevascularized devices and related methods
09/04/2012CA2558661C Load bearing biocompatible device
09/04/2012CA2543865C Compositions comprising cyclohexylamines and aminoadamantanes
09/04/2012CA2541834C Modified whole cell, cell extract and omv-based vaccines
09/04/2012CA2541009C Monodispersed solid lipid particle compositions
09/04/2012CA2538727C Hydrogel compositions with an erodible backing member
09/04/2012CA2528411C Method for improving stability and shelf-life of liposome complexes
09/04/2012CA2524271C Controlled release bioactive agent delivery device
09/04/2012CA2513276C Compositions containing coenzyme q10
09/03/2012CA2765636A1 Patch and patch preparation
08/2012
08/30/2012WO2012116357A2 Use of agr3 for treating cancer
08/30/2012WO2012116282A2 Protein nanocarriers for topical delivery
08/30/2012WO2012116272A2 Polymer conjugated protein micelles
08/30/2012WO2012116229A2 Compositions and methods for personal tumor profiling treatment
08/30/2012WO2012116225A2 Muc1 based glycolipopeptide vaccine with adjuvant
08/30/2012WO2012116066A1 Controlled release hydrogel formulation
08/30/2012WO2012116018A1 Spray dried myrosinase and use to produce isothiocyanates
08/30/2012WO2012115772A2 Therapy for kidney disease and/or heart failure
08/30/2012WO2012115771A2 Systems and methods for therapy of kidney disease and/or heart failure using chimeric natriuretic peptides
08/30/2012WO2012115659A1 Compositions and methods for controlled delivery of compounds
08/30/2012WO2012115655A1 Formulations of canfosfamide and their preparation
08/30/2012WO2012115640A1 Liquid insulin- containing compositions and methods of making the same
08/30/2012WO2012115619A1 Loading system for an encapsulation device
08/30/2012WO2012115298A1 Agent for treating urinary incontinence including stem cells derived from amniotic fluid
08/30/2012WO2012115222A1 Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing same
08/30/2012WO2012115207A1 Biologically active nonaqueous composition for microneedle devices, and biologically active nonaqueous composition adhering to microneedle
08/30/2012WO2012114352A2 Pharmaceutical compositions of maraviroc and process for the preparation thereof
08/30/2012WO2012114201A1 Nanocapsulation of essential oils for preventing or curing infectious diseases alone or with an antibiotic
08/30/2012WO2012114131A1 Lecithin:cholesterol acyltransferase (lcat) and its role in nonalcoholic fatty liver disease (nafld)
08/30/2012WO2012114054A1 Locally acting pharmaceutical compositions which can be administered by cutaneous application
08/30/2012WO2012114051A1 Cutaneous pharmaceutical compositions for the local treatment of canine atopic dermatitis
08/30/2012WO2012113918A1 Composition comprising thylakoids for delaying the uptake of molecules
08/30/2012WO2012113894A1 Pharmaceutical combination of betahistine and trimetazidine
08/30/2012WO2012113564A1 Stabilized granules containing glyceryl trinitrate
08/30/2012WO2012113563A1 Packaging of solid pharmaceutical preparations containing the active substance glyceryl trinitrate
08/30/2012WO2012113179A1 Sustained release pharmaceutical composition of zaltoprofen and preparation method thereof
08/30/2012WO2012113117A1 Oral preparation comprising protein or polypeptide, preparation method thereof, and use thereof
08/30/2012WO2012113116A1 Emulsion containing hydrophilic biological macromolecule, preparation method and application thereof
08/30/2012WO2012113060A1 Apparatus for the controlled release of topical nitric oxide
08/30/2012WO2012092990A3 Medical product for improving the ability of a mammal to conceive
08/30/2012WO2012089811A3 Transdermal application system comprising a protruding backing film
08/30/2012WO2012085657A3 Tamper resistant solid oral dosage forms
08/30/2012WO2012080184A3 Liquid pharmaceutical compositions which can be administered orally and contain 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophene carboxamide
08/30/2012WO2012079671A3 Method for producing δ-mannitol which can be directly tableted
08/30/2012WO2012077001A3 Wipe coated with a botanical emulsion having anitmicrobial properties
08/30/2012WO2012068476A3 Poly(vinyl benzoate) nanoparticles for molecular delivery
08/30/2012WO2012057492A3 Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein a-i and a mutant thereof
08/30/2012WO2012053012A3 Topical pharmaceutical compositions comprising tfflocolchicoside
08/30/2012WO2012016707A3 Oral dosage form for the modified release of dimebolin
08/30/2012WO2012013782A3 Compositions for controlling heartworm infestation
08/30/2012WO2012001156A3 Pharmaceutical oral dosage forms comprising dabigatran etexilate and its pharmaceutically acceptable salts
08/30/2012WO2011161246A3 Swellable substance actuator and delivery device, in particular for a medicinal active substance
08/30/2012WO2011149877A3 Intestinal brake inducing intraluminal therapeutic substance eluting devices and methods
08/30/2012WO2011121019A3 Method for producing a drug delivery system on the basis of polyelectrolyte complexes
08/30/2012US20120220961 Ophthalmic Solutions
08/30/2012US20120220921 Immunologically modified carbon nanotubes for cancer treatment
08/30/2012US20120220764 Method for producing a crystalline tableting additive, additive thus obtained and use thereof
08/30/2012US20120220666 Composition to enhance the bioavailability of curcumin
08/30/2012US20120220578 Gum resin as a carrier for topical application of pharmacologically active agents
08/30/2012US20120220559 Controlled Release and Taste Masking Oral Pharmaceutical Composition
08/30/2012US20120219631 Modified release formulation of lacosamide
08/30/2012US20120219630 Treatment of Urinary Incontinence Using Nitrone Spin Traps
08/30/2012US20120219629 Compositions and methods for controlled delivery of compounds
08/30/2012US20120219628 Fast dissolving solid dosage form
08/30/2012US20120219627 Compositions and improved soft tissue replacement methods
08/30/2012US20120219626 Pharmaceutical Compositions of Sevelamer
08/30/2012US20120219625 Clarithromycin extended-release tablet
08/30/2012US20120219624 Process for preparing products comprising stabilised actives and compositions comprising same
08/30/2012US20120219623 Pharmaceutical compositions comprising bi-1356 and metformin
08/30/2012US20120219622 Dpp iv inhibitor formulations
08/30/2012US20120219621 Composition with Enhanced Thermogenic Activity and the Use Thereof in the Prevention and Treatment of Obesity
08/30/2012US20120219620 SCF Extract Containing Cardiac Glycoside
08/30/2012US20120219619 Substances for reducing occurrence of major cardiac events in humans
08/30/2012US20120219618 Spla2 hydrolysable liposomes with improved storage stability
08/30/2012US20120219617 MUC1 Based Glycolipopeptide Vaccine with Adjuvant
08/30/2012US20120219616 LIPOSOMAL REDUCED GLUTATHIONE AND l-ARGININE, INCLUDING WITH OTHER INGREDIENT(S), CAPABLE OF MULTIPATH ADMINISTRATION FOR REVERSAL AND PREVENTION OF OBESITY AND FOR MITOCHONDRIAL BIOGENESIS
08/30/2012US20120219615 Therapeutic Use of a TLR Agonist and Combination Therapy
08/30/2012US20120219614 Methods and compositions for preventing a condition
08/30/2012US20120219613 Novel Antiviral Agents for Enveloped Viruses
08/30/2012US20120219611 Hypotensive lipid-containing biodegradable intraocular implants and related methods
08/30/2012US20120219605 Adjuvanted nanoparticulate influenza vaccine
08/30/2012US20120219604 Method of solubilizing poorly soluble/insoluble active material through formation of oligomer composite
08/30/2012US20120219603 Use of Calcitonin for the Treatment of RA
08/30/2012US20120219602 Methods for treating herpes virus infections
08/30/2012US20120219601 Composition Comprising Biodegradable Hydrating Ceramics for Controlled Drug Delivery
1 ... 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 ... 2991